New promising treatments for Alzheimer’s disease may not be as beneficial for black and Hispanic sufferers. Leqembi and donanemab, an experimental antibody developed by Eli Lilly, are the first dru… [+2133 chars]Read More
Hispanic black Alzheimers patients excluded from new treatment testing New York Post
